- Home
- BDX
as 08-22-2025 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 49.0B | IPO Year: | 1962 |
| Target Price: | $222.75 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.47 | EPS Growth: | 12.91 |
| 52 Week Low/High: | $163.33 - $251.99 | Next Earning Date: | 08-07-2025 |
| Revenue: | $21,386,000,000 | Revenue Growth: | 7.86% |
| Revenue Growth (this year): | 9.24% | Revenue Growth (next year): | 4.88% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Shan David | BDX | EVP and Chief ISC Officer | Jun 2 '25 | Sell | $171.19 | 1,166 | $199,607.54 | 4,575 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Morningstar Research
5 days ago
Analyst Report: Becton, Dickinson and Company
Barchart
7 days ago
Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish?
StockStory
7 days ago
Surgical Equipment & Consumables - Diversified Stocks Q2 Results: Benchmarking BD (NYSE:BDX)
PR Newswire
10 days ago
BD to Present at Wells Fargo 2025 Healthcare Conference
GlobeNewswire
11 days ago
ASEAN Infusion Pump Company Evaluation Report 2025 | BD, Fresenius Kabi, and Terumo Lead with Innovations in Drug Delivery, Hospital Care, and Cardiovascular Solutions
Simply Wall St.
11 days ago
We Like The Quality Of Becton Dickinson's (NYSE:BDX) Earnings
StockStory
11 days ago
5 Revealing Analyst Questions From BD’s Q2 Earnings Call
![[Latest] US Surgical Instrument Tracking Market Size/Share Worth USD 226.61 Million by 2034 at a 11.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/cdn/transform/width=500,quality=90,format=webp/https://cdn.finquota.com/news/f13dc56e-e10d-48b3-b6be-826d5ea26eab.png)
GlobeNewswire
13 days ago
[Latest] US Surgical Instrument Tracking Market Size/Share Worth USD 226.61 Million by 2034 at a 11.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.